Anti-NAT1 Antibody

The cytosolic arylamine N-acetyltransferase 1 (NAT1) enzyme catalyzes acetyl group transfer from acetyl-CoA to aromatic amines and hydrazines, driving xenobiotic biotransformation, folate catabolism, and the metabolic activation or detoxification of procarcinogens. Antibodies.com offers this rabbit polyclonal reagent, unconjugated, raised against the NAT1 target and validated for Western blot and immunohistochemistry workflows on human, mouse, and rat samples.

The antibody is supplied in a 100 µl vial, sufficient for multiple membrane probing experiments or tissue section staining runs, and supports investigation of NAT1 polymorphisms that alter enzyme kinetics in tumor biology, bladder carcinogenesis models, and breast cancer susceptibility research. Because NAT1 is expressed across epithelial and hepatic tissues, researchers apply this reagent to cell lysates, tumor xenograft sections, and tissue microarrays to compare expression across genotypes and treatment conditions.

The unconjugated format permits flexible pairing with secondary antibodies matched to a chosen detection label, supporting chromogenic IHC, immunofluorescence, and chemiluminescent Western blot readouts depending on the experimental aim.